The group of Sato et al. demonstrated that cervical cancer cells express the enzyme IDO and that its inhibition with interfering RNA improves the response of NK cells in vitro and in vivo, promoting the better elimination of tumour cells and a reduction in tumour size associated with NK cell infiltration. This evidence concerns the gene IDO1 and cervical cancer.